Global Blood Therapeutics, Inc.
Modulators of hemoglobin

Last updated:

Abstract:

The present disclosure relates generally to compounds and pharmaceutical compositions suitable as modulators of hemoglobin, and methods for their use in treating disorders mediated by hemoglobin.

Status:
Grant
Type:

Utility

Filling date:

30 Sep 2019

Issue date:

25 May 2021